Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021

Loading...
Loading...

 

Upgrades

  • Argus Research upgraded the previous rating for The Chemours Co CC from Hold to Buy. Chemours earned $0.71 in the first quarter, compared to $0.71 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.17 and a 52-week-low of $10.62. Chemours closed at $33.78 at the end of the last trading period.
  • According to Argus Research, the prior rating for Restaurant Brands International Inc QSR was changed from Hold to Buy. In the first quarter, Restaurant Brands Intl earned $0.55. The stock has a 52-week-high of $71.12 and a 52-week-low of $48.09. At the end of the last trading period, Restaurant Brands Intl closed at $69.01.
  • According to Raymond James, the prior rating for Maxeon Solar Technologies Ltd MAXN was changed from Outperform to Strong Buy. In the fourth quarter, Maxeon Solar Technologies showed an EPS of $0.11, compared to $1.51 from the year-ago quarter. At the moment, the stock has a 52-week-high of $57.97 and a 52-week-low of $11.78. Maxeon Solar Technologies closed at $15.43 at the end of the last trading period.
  • Craig-Hallum upgraded the previous rating for Hudson Technologies Inc HDSN from Hold to Buy. For the first quarter, Hudson Technologies had an EPS of $0.02, compared to year-ago quarter EPS of $0.07. The stock has a 52-week-high of $2.25 and a 52-week-low of $0.78. At the end of the last trading period, Hudson Technologies closed at $1.92.
  • According to Citigroup, the prior rating for Alcon Inc ALC was changed from Sell to Neutral. Alcon earned $0.49 in the first quarter, compared to $0.45 in the year-ago quarter. The current stock performance of Alcon shows a 52-week-high of $76.53 and a 52-week-low of $51.01. Moreover, at the end of the last trading period, the closing price was at $70.14.
  • For Accolade Inc ACCD, SVB Leerink upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, Accolade earned $0.22. The stock has a 52-week-high of $65.25 and a 52-week-low of $29.50. At the end of the last trading period, Accolade closed at $45.05.
  • For Neurocrine Biosciences Inc NBIX, Barclays upgraded the previous rating of Equal-Weight to Overweight. Neurocrine Biosciences earned $0.49 in the first quarter, compared to $0.82 in the year-ago quarter. At the moment, the stock has a 52-week-high of $136.26 and a 52-week-low of $86.02. Neurocrine Biosciences closed at $91.60 at the end of the last trading period.
  • Stephens & Co. upgraded the previous rating for WideOpenWest Inc WOW from Equal-Weight to Overweight. For the first quarter, WideOpenWest had an EPS of $0.11, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $18.20 and a 52-week-low of $4.72. WideOpenWest closed at $15.38 at the end of the last trading period.
  • For Zynga Inc ZNGA, B of A Securities upgraded the previous rating of Neutral to Buy. Zynga earned $0.08 in the first quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $12.32 and a 52-week-low of $7.42. Zynga closed at $10.14 at the end of the last trading period.
  • For Astec Industries Inc ASTE, Stifel upgraded the previous rating of Hold to Buy. For the first quarter, Astec Industries had an EPS of $0.41, compared to year-ago quarter EPS of $1.00. The current stock performance of Astec Industries shows a 52-week-high of $80.00 and a 52-week-low of $34.50. Moreover, at the end of the last trading period, the closing price was at $65.95.
  • For Flex Ltd FLEX, Cross Research upgraded the previous rating of Hold to Buy. In the fourth quarter, Flex showed an EPS of $0.49, compared to $0.28 from the year-ago quarter. The stock has a 52-week-high of $20.04 and a 52-week-low of $8.71. At the end of the last trading period, Flex closed at $17.66.
  • According to Stifel, the prior rating for MercadoLibre Inc MELI was changed from Hold to Buy. MercadoLibre earned $0.68 in the first quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $2020.00 and a 52-week-low of $610.83. At the end of the last trading period, MercadoLibre closed at $1530.54.
  • Cowen & Co. upgraded the previous rating for Darden Restaurants Inc DRI from Market Perform to Outperform. In the third quarter, Darden Restaurants showed an EPS of $0.98, compared to $1.90 from the year-ago quarter. The current stock performance of Darden Restaurants shows a 52-week-high of $149.73 and a 52-week-low of $61.21. Moreover, at the end of the last trading period, the closing price was at $142.10.
  • Citigroup upgraded the previous rating for Ultragenyx Pharmaceutical Inc RARE from Neutral to Buy. For the first quarter, Ultragenyx Pharmaceutical had an EPS of $2.03, compared to year-ago quarter EPS of $2.05. At the moment, the stock has a 52-week-high of $179.65 and a 52-week-low of $61.96. Ultragenyx Pharmaceutical closed at $106.01 at the end of the last trading period.
  • For Personalis Inc PSNL, Oppenheimer upgraded the previous rating of Perform to Outperform. In the first quarter, Personalis showed an EPS of $0.29, compared to $0.29 from the year-ago quarter. The stock has a 52-week-high of $53.46 and a 52-week-low of $9.69. At the end of the last trading period, Personalis closed at $21.04.
  • Mizuho upgraded the previous rating for Evolus Inc EOLS from Neutral to Buy. Evolus earned $0.81 in the fourth quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $17.38 and a 52-week-low of $2.85. At the end of the last trading period, Evolus closed at $8.88.
  • According to B. Riley FBR, the prior rating for Cumulus Media Inc CMLS was changed from Neutral to Buy. For the first quarter, Cumulus Media had an EPS of $1.07, compared to year-ago quarter EPS of $0.36. At the moment, the stock has a 52-week-high of $11.75 and a 52-week-low of $3.00. Cumulus Media closed at $9.00 at the end of the last trading period.
  • According to Berenberg, the prior rating for National Grid PLC NGG was changed from Hold to Buy. At the moment, the stock has a 52-week-high of $63.78 and a 52-week-low of $53.09. National Grid closed at $63.46 at the end of the last trading period.
  • According to Evercore ISI Group, the prior rating for Ultragenyx Pharmaceutical Inc RARE was changed from In-Line to Outperform. Ultragenyx Pharmaceutical earned $2.03 in the first quarter, compared to $2.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $179.65 and a 52-week-low of $61.96. Ultragenyx Pharmaceutical closed at $106.01 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • According to Citigroup, the prior rating for FMC Corp FMC was changed from Buy to Neutral. In the first quarter, FMC showed an EPS of $1.53, compared to $1.84 from the year-ago quarter. At the moment, the stock has a 52-week-high of $123.66 and a 52-week-low of $85.58. FMC closed at $121.95 at the end of the last trading period.
  • According to Truist Securities, the prior rating for Pioneer Natural Resources Co PXD was changed from Buy to Hold. For the first quarter, Pioneer Natural Resources had an EPS of $1.77, compared to year-ago quarter EPS of $1.15. The stock has a 52-week-high of $169.49 and a 52-week-low of $76.48. At the end of the last trading period, Pioneer Natural Resources closed at $164.30.
  • According to Benchmark, the prior rating for Cross Country Healthcare Inc CCRN was changed from Buy to Hold. Cross Country Healthcare earned $0.58 in the first quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Cross Country Healthcare shows a 52-week-high of $14.55 and a 52-week-low of $4.50. Moreover, at the end of the last trading period, the closing price was at $14.19.
  • For Donnelley Financial Solutions Inc DFIN, DA Davidson downgraded the previous rating of Buy to Neutral. For the first quarter, Donnelley Financial Solns had an EPS of $1.15, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $31.87 and a 52-week-low of $5.94. At the end of the last trading period, Donnelley Financial Solns closed at $30.17.
  • For Unitil Corp UTL, B of A Securities downgraded the previous rating of Neutral to Underperform. For the first quarter, Unitil had an EPS of $1.26, compared to year-ago quarter EPS of $1.02. The current stock performance of Unitil shows a 52-week-high of $59.32 and a 52-week-low of $32.80. Moreover, at the end of the last trading period, the closing price was at $55.20.
  • According to B of A Securities, the prior rating for Peloton Interactive Inc PTON was changed from Buy to Neutral. The current stock performance of Peloton Interactive shows a 52-week-high of $171.09 and a 52-week-low of $34.25. Moreover, at the end of the last trading period, the closing price was at $82.62.
  • According to DA Davidson, the prior rating for General Finance Corp GFN was changed from Buy to Neutral. For the third quarter, General Finance had an EPS of $0.33, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $19.30 and a 52-week-low of $4.62. General Finance closed at $18.95 at the end of the last trading period.
  • According to Mizuho, the prior rating for Pfizer Inc PFE was changed from Buy to Neutral. For the first quarter, Pfizer had an EPS of $0.93, compared to year-ago quarter EPS of $0.80. The current stock performance of Pfizer shows a 52-week-high of $43.08 and a 52-week-low of $31.61. Moreover, at the end of the last trading period, the closing price was at $39.95.

See all analyst ratings downgrades.

 

Initiations

  • With a Buy rating, Guggenheim initiated coverage on Freeline Therapeutics Holdings PLC FRLN. The price target seems to have been set at $17.00 for Freeline Therapeutics. NoneThe current stock performance of Freeline Therapeutics shows a 52-week-high of $19.89 and a 52-week-low of $11.00. Moreover, at the end of the last trading period, the closing price was at $11.12.
  • Maxim Group initiated coverge on Biotricity, Inc. BTCY with a Buy rating and a price target of $6. Biotricity shares were down 6.25% to $2.45 on Thursday.
  • Stifel initiated coverage on CTI BioPharma Corp CTIC with a Buy rating. The price target for CTI BioPharma is set to $5.50. In the fourth quarter, CTI BioPharma showed an EPS of $0.20, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $4.13 and a 52-week-low of $0.96. At the end of the last trading period, CTI BioPharma closed at $2.34.
  • Credit Suisse initiated coverage on Paya Holdings Inc PAYA with an Outperform rating. The price target for Paya Holdings is set to $14.00. Paya Holdings earned $0.09 in the fourth quarter. The current stock performance of Paya Holdings shows a 52-week-high of $15.00 and a 52-week-low of $10.38. Moreover, at the end of the last trading period, the closing price was at $10.57.
  • With a Buy rating, Canaccord Genuity initiated coverage on Tilray Inc TLRY. The price target seems to have been set at $17.00 for Tilray. In the fourth quarter, Tilray showed an EPS of $0.45, compared to $0.62 from the year-ago quarter. The current stock performance of Tilray shows a 52-week-high of $67.00 and a 52-week-low of $4.41. Moreover, at the end of the last trading period, the closing price was at $15.90.

See all analyst ratings initiations.

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Penny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...